Innovent Biologics, Inc. (HKG:1801)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
50.25
+0.40 (0.80%)
Apr 3, 2025, 4:08 PM HKT

Innovent Biologics Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2016 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Market Capitalization
82,31959,95669,33351,40370,547115,098
Upgrade
Market Cap Growth
-13.53%-13.53%34.88%-27.14%-38.71%243.36%
Upgrade
Enterprise Value
76,94254,28363,85044,89959,352109,367
Upgrade
Last Close Price
50.2536.6042.7533.5048.2582.05
Upgrade
PS Ratio
8.165.9810.149.9813.4625.21
Upgrade
PB Ratio
5.884.305.024.245.5611.04
Upgrade
P/TBV Ratio
4.764.765.044.255.5711.04
Upgrade
P/OCF Ratio
-425.78---
Upgrade
EV/Sales Ratio
7.675.419.348.7211.3323.96
Upgrade
Debt / Equity Ratio
0.220.220.290.300.240.14
Upgrade
Asset Turnover
0.450.450.330.270.300.40
Upgrade
Inventory Turnover
2.692.691.511.001.191.45
Upgrade
Quick Ratio
2.082.082.682.783.275.85
Upgrade
Current Ratio
2.352.353.003.293.796.37
Upgrade
Return on Equity (ROE)
-0.74%-0.74%-8.84%-20.70%-28.56%-14.75%
Upgrade
Return on Assets (ROA)
-2.24%-2.24%-5.12%-11.54%-12.04%-3.65%
Upgrade
Return on Capital (ROIC)
-2.94%-2.94%-6.49%-14.57%-14.81%-4.46%
Upgrade
Earnings Yield
-0.12%-0.17%-1.63%-4.79%-4.75%-1.03%
Upgrade
FCF Yield
--1.54%-6.19%-5.38%-0.82%
Upgrade
Buyback Yield / Dilution
-4.35%-4.35%-4.67%-2.37%-7.27%-15.23%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.